Pan Asia Medicine, as a modern biotechnology enterprise integrating "production, education, research and application" of food and medicine Cordyceps fungi, has accelerated the launch of new cicada flower health products and increased the cultivation and production of cicada flowe

" Cordyceps type edible medicinal fungi are precious natural resources. They are rich in diverse biological activities and nutrients, and have incomparable natural advantages in regulating immunity , nutritional support, etc.". At the "2022 World Cordyceps Forum", the experts at the meeting clearly put forward this view.

"Enhance physical fitness and improve individual immunity is an important means of disease prevention, treatment and rehabilitation." Professor Li Zengzhi, a famous mycologist and president of the Pan-Asian Institute of Life Sciences, also fully affirmed the value of Cordyceps resources in this area. Pan Asia Medicine, as an integrated "production, education, research and application" of ed.2 modern biotechnology enterprise for food and medicine, has accelerated the launch of new cicada flower health products and increased the cultivation and production of cicada flower, and launched the "Sunshade Plan": From today until March 31, 2023, at very high prices and great dedication, more families will have a "gift package to protect family health" to help the whole family be healthy.

Cicada flower is a rare cordyceps. Pan Asia Pharmaceuticals, led by academicians and doctoral leaders, has achieved industrial cultivation of cicada flowers after 15 years of painstaking efforts: In December 2018, the cicada flower strains and cultivation technology independently owned by Pan Asia Pharmaceutical won the "China Patent Gold Award"; in January 2021, the cicada flower fruit entity (artificial cultivation) originally developed by Pan Asia Pharmaceutical was approved by the state as a "new food raw material"; in December 2021, the cicada flower of Pan Asia Pharmaceutical was awarded the " new plant variety right ", and was protected by the national new plant variety. The cicada flower of Pan Asia Pharmaceutical has become a "newcomer" in the field of Cordyceps sinensis in China, and has obtained the production and sales license of Swedish , and has developed the Swedish version of "Cikaria" and is popular in EU . Cicada Flower (artificial cultivation) As a practitioner of the Cordyceps health industry, Pan Asia Pharmaceutical has donated cicada flower health products to the front line of the fight against the epidemic many times during the three years of the epidemic to help fight the epidemic: In March 2020, through the "Beijing Wuliande Charity Foundation", through the "Zhejiang Provincial Red Cross Society", to the Zhejiang medical team to Hubei, and through the "Huai'an Economic and Technological Development Zone Charity Federation", to the front-line medical staff in Huai'an, Jiangsu Province; in April 2022, four times, through the " Shanghai Charity Foundation ", "Shanghai Hu Jinhua Health Education Promotion Association", and other institutions, a large number of Cordyceps special drinks and other health products to more than 20 "third-class" hospitals, square hospitals , and medical institutions in Shanghai.

Edited by: Liu Liyuan